vs

Side-by-side financial comparison of Emerson Electric (EMR) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.

Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $4.3B, roughly 1.3× Emerson Electric). Emerson Electric runs the higher net margin — 13.9% vs 7.9%, a 6.0% gap on every dollar of revenue. On growth, Emerson Electric posted the faster year-over-year revenue change (4.1% vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.

EMR vs FMS — Head-to-Head

Bigger by revenue
FMS
FMS
1.3× larger
FMS
$5.5B
$4.3B
EMR
Growing faster (revenue YoY)
EMR
EMR
+4.4% gap
EMR
4.1%
-0.3%
FMS
Higher net margin
EMR
EMR
6.0% more per $
EMR
13.9%
7.9%
FMS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMR
EMR
FMS
FMS
Revenue
$4.3B
$5.5B
Net Profit
$605.0M
$434.2M
Gross Margin
53.2%
27.4%
Operating Margin
17.8%
11.7%
Net Margin
13.9%
7.9%
Revenue YoY
4.1%
-0.3%
Net Profit YoY
3.4%
240.4%
EPS (diluted)
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
FMS
FMS
Q4 25
$4.3B
$5.5B
Q3 25
$4.9B
Q2 25
$4.6B
Q1 25
$4.4B
Q4 24
$4.2B
$5.5B
Q3 24
$4.6B
Q2 24
$4.4B
Q1 24
$4.4B
Net Profit
EMR
EMR
FMS
FMS
Q4 25
$605.0M
$434.2M
Q3 25
$637.0M
Q2 25
$586.0M
Q1 25
$485.0M
Q4 24
$585.0M
$127.6M
Q3 24
$996.0M
Q2 24
$329.0M
Q1 24
$501.0M
Gross Margin
EMR
EMR
FMS
FMS
Q4 25
53.2%
27.4%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
25.0%
Q3 24
51.3%
Q2 24
52.8%
Q1 24
52.2%
Operating Margin
EMR
EMR
FMS
FMS
Q4 25
17.8%
11.7%
Q3 25
16.4%
Q2 25
16.1%
Q1 25
14.2%
Q4 24
18.6%
5.1%
Q3 24
14.7%
Q2 24
10.4%
Q1 24
16.2%
Net Margin
EMR
EMR
FMS
FMS
Q4 25
13.9%
7.9%
Q3 25
13.1%
Q2 25
12.9%
Q1 25
10.9%
Q4 24
14.0%
2.3%
Q3 24
21.6%
Q2 24
7.5%
Q1 24
11.4%
EPS (diluted)
EMR
EMR
FMS
FMS
Q4 25
$1.07
Q3 25
$1.12
Q2 25
$1.04
Q1 25
$0.86
Q4 24
$1.02
Q3 24
$1.74
Q2 24
$0.57
Q1 24
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
FMS
FMS
Cash + ST InvestmentsLiquidity on hand
$1.7B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$20.3B
$15.4B
Total Assets
$41.9B
$33.5B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
FMS
FMS
Q4 25
$1.7B
Q3 25
Q2 25
Q1 25
Q4 24
$1.3B
Q3 24
Q2 24
Q1 24
Total Debt
EMR
EMR
FMS
FMS
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
EMR
EMR
FMS
FMS
Q4 25
$20.3B
$15.4B
Q3 25
$20.3B
Q2 25
$19.9B
Q1 25
$19.2B
Q4 24
$20.5B
$17.0B
Q3 24
$21.6B
Q2 24
$20.8B
Q1 24
$20.9B
Total Assets
EMR
EMR
FMS
FMS
Q4 25
$41.9B
$33.5B
Q3 25
$42.0B
Q2 25
$42.5B
Q1 25
$42.0B
Q4 24
$42.6B
$36.3B
Q3 24
$44.2B
Q2 24
$45.6B
Q1 24
$46.4B
Debt / Equity
EMR
EMR
FMS
FMS
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
FMS
FMS
Operating Cash FlowLast quarter
$699.0M
$2.9B
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
6.67×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
FMS
FMS
Q4 25
$699.0M
$2.9B
Q3 25
$3.1B
Q2 25
$1.1B
Q1 25
$241.0M
Q4 24
$777.0M
$2.6B
Q3 24
$3.3B
Q2 24
$1.1B
Q1 24
$743.0M
Free Cash Flow
EMR
EMR
FMS
FMS
Q4 25
$602.0M
Q3 25
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$998.0M
Q1 24
$661.0M
FCF Margin
EMR
EMR
FMS
FMS
Q4 25
13.9%
Q3 25
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
22.8%
Q1 24
15.1%
Capex Intensity
EMR
EMR
FMS
FMS
Q4 25
2.2%
Q3 25
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
2.1%
Q1 24
1.9%
Cash Conversion
EMR
EMR
FMS
FMS
Q4 25
1.16×
6.67×
Q3 25
4.86×
Q2 25
1.83×
Q1 25
0.50×
Q4 24
1.33×
20.20×
Q3 24
3.35×
Q2 24
3.31×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

FMS
FMS

Segment breakdown not available.

Related Comparisons